Balamurugan N. Appakalai
Directeur/Membre du Conseil chez Koligo Therapeutics, Inc.
Provenance du réseau au premier degré de Balamurugan N. Appakalai
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Koligo Therapeutics, Inc.
 Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Balamurugan N. Appakalai via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CALLITAS HEALTH INC. | Pharmaceuticals: Major | Chief Executive Officer | |
SPRI Clinical Trials-Global LLC
 SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services SPRI Clinical Trials-Global LLC engages in the provision of clinical research solutions. It offers quality assurance, feasibility and site selection, regulatory management, project management, clinical monitoring, and biometrics. The company was founded by Nick Vatakis in 1972 and is headquartered in Pittsboro, NC. | Miscellaneous Commercial Services | Chief Operating Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
| IMMUTEP LIMITED | Biotechnology | Chief Executive Officer | |
| University of Delaware | College/University | Doctorate Degree | |
| University of Louisville | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
Association of Clinical Research Professionals
 Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| European Business Association | Corporate Officer/Principal | ||
Koligo Therapeutics Ltd.
 Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | Medical Specialties | Chief Executive Officer Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 9 |
| Australie | 3 |
| Ukraine | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 5 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 7 |
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Operating Officer | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Matthew Lehman | 9 |
| Stuart K. Williams | 6 |
| Mike Hughes | 1 |
- Bourse
- Insiders
- Balamurugan N. Appakalai
- Connexions Sociétés
